Director/PDMR Shareholding

RNS Number : 6367T
Venture Life Group PLC
25 July 2022

25 July 2022


("Venture Life" "VLG" or the "Group")

Director Dealings

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that Paul Mcgreevy, Non-Executive Chairman, today purchased 277,151 ordinary shares of 0.3p each in the Company ("Ordinary Shares") at a volume weighted average price of 35.0 pence per Ordinary Share.

Following this purchase, Mr Mcgreevy beneficially holds 564,590 Ordinary Shares representing 0.45 per cent. of the Company's issued share capital.


For further information, please contact:


Venture Life Group PLC

+44 (0) 1344 578004

Jerry Randall, Chief Executive Officer

Daniel Wells, Chief Financial Officer


Cenkos Securities plc (Nomad and Broker)


+44 (0) 20 7397 8900

Stephen Keys / Camilla Hume


Russell Kerr / Michael Johnson (Sales)



Singer Capital Markets (Joint Broker)

Shaun Dobson / Alaina Wong  (Corporate Finance)    

Jonathan Dighe (Sales)



+44 (0) 20 7496 3000



About Venture Life ( )

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.


The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands, these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. 


Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies for consumer healthcare products, primarily medical devices.



The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:



Details of the person discharging managerial responsibilities / person closely associated







Paul Mcgreevy




Reason for the notification







Non-Executive Chariman



Initial notification /Amendment



Initial notification



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor







Venture Life Group plc









Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted





Description of the financial instrument, type of instrument



Identification code



Ordinary Shares of 0.3p each in Venture Life Group plc







Nature of the transaction



Purchase of ordinary shares



Price(s) and volume(s)



234,285 ordinary shares at 35.000 pence per share

42,866 ordinary shares at 34.992 pence per share





Aggregated information



- Aggregated volume



- Price



See above










Date of the transaction



25 July 2022



Place of the transaction



London Stock Exchange




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings